skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Folfirinox Regimen (Code C11764)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Folfirinox Regimen

Definition: A regimen consisting of fluorouracil, irinotecan hydrochloride, leucovorin calcium and oxaliplatin used for the treatment of pancreatic cancer.

Display Name: Folfirinox Regimen

Label: Folfirinox Regimen

NCI Thesaurus Code: C11764 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0879464  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Fluorouracil/irinotecan/leucovorin calcium/oxaliplatin
Fluorouracil with Irinotecan Hydrochloride, Leucovorin Calcium and Oxaliplatin
Folfirinox Protocol
Folfirinox Regimen

External Source Codes: 
PDQ Closed Trial Search ID 710968
PDQ Open Trial Search ID 710968 (check for NCI PDQ open clinical trial info)
UMLS CUI C0879464

Other Properties:
     Name Value (qualifiers indented underneath)
code C11764
Contributing_Source CTRP
Legacy_Concept_Name Fluorouracil_irinotecan_leucovorin-calcium_oxaliplatin
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom